224 related articles for article (PubMed ID: 37191809)
1. Gain-of-Function Variomics and Multi-omics Network Biology for Precision Medicine.
Li MM; Awasthi S; Ghosh S; Bisht D; Coban Akdemir ZH; Sheynkman GM; Sahni N; Yi SS
Methods Mol Biol; 2023; 2660():357-372. PubMed ID: 37191809
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology.
Li Y; Zhang Y; Li X; Yi S; Xu J
Trends Biochem Sci; 2019 Aug; 44(8):659-674. PubMed ID: 31047772
[TBL] [Abstract][Full Text] [Related]
3. Functional variomics and network perturbation: connecting genotype to phenotype in cancer.
Yi S; Lin S; Li Y; Zhao W; Mills GB; Sahni N
Nat Rev Genet; 2017 Jul; 18(7):395-410. PubMed ID: 28344341
[TBL] [Abstract][Full Text] [Related]
4. Molecular and Phenotypic Characterization of Nine Patients with STAT1 GOF Mutations in China.
Chen X; Xu Q; Li X; Wang L; Yang L; Chen Z; Zeng T; Xue X; Xu T; Wang Y; Jia Y; Zhao Q; Wu J; Liang F; Tang X; Yang J; An Y; Zhao X
J Clin Immunol; 2020 Jan; 40(1):82-95. PubMed ID: 31686315
[TBL] [Abstract][Full Text] [Related]
5. Pathway perturbations in signaling networks: Linking genotype to phenotype.
Li Y; McGrail DJ; Latysheva N; Yi S; Babu MM; Sahni N
Semin Cell Dev Biol; 2020 Mar; 99():3-11. PubMed ID: 29738884
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
Front Immunol; 2021; 12():654406. PubMed ID: 33777053
[No Abstract] [Full Text] [Related]
7. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
Edwards ESJ; Bier J; Cole TS; Wong M; Hsu P; Berglund LJ; Boztug K; Lau A; Gostick E; Price DA; O'Sullivan M; Meyts I; Choo S; Gray P; Holland SM; Deenick EK; Uzel G; Tangye SG
J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648
[TBL] [Abstract][Full Text] [Related]
8. Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.
Marega LF; Sabino JS; Pedroni MV; Teocchi M; Lanaro C; de Albuquerque DM; Dos Santos IP; Costa FF; Dos Santos Vilela MM
Immunol Res; 2021 Oct; 69(5):445-456. PubMed ID: 34390446
[TBL] [Abstract][Full Text] [Related]
9. Activating mutations of STAT3: Impact on human growth.
Gutiérrez M
Mol Cell Endocrinol; 2020 Dec; 518():110979. PubMed ID: 32818584
[TBL] [Abstract][Full Text] [Related]
10. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.
Kagawa R; Fujiki R; Tsumura M; Sakata S; Nishimura S; Itan Y; Kong XF; Kato Z; Ohnishi H; Hirata O; Saito S; Ikeda M; El Baghdadi J; Bousfiha A; Fujiwara K; Oleastro M; Yancoski J; Perez L; Danielian S; Ailal F; Takada H; Hara T; Puel A; Boisson-Dupuis S; Bustamante J; Casanova JL; Ohara O; Okada S; Kobayashi M
J Allergy Clin Immunol; 2017 Jul; 140(1):232-241. PubMed ID: 28011069
[TBL] [Abstract][Full Text] [Related]
11. Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.
Faletti L; Ehl S; Heeg M
Biomed J; 2021 Aug; 44(4):412-421. PubMed ID: 34366294
[TBL] [Abstract][Full Text] [Related]
12. TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer.
Chapman L; Ledet EM; Barata PC; Cotogno P; Manogue C; Moses M; Christensen BR; Steinwald P; Ranasinghe L; Layton JL; Lewis BE; Sartor O
Clin Genitourin Cancer; 2020 Apr; 18(2):148-154. PubMed ID: 31822380
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide prediction of pathogenic gain- and loss-of-function variants from ensemble learning of a diverse feature set.
Stein D; Kars ME; Wu Y; Bayrak ÇS; Stenson PD; Cooper DN; Schlessinger A; Itan Y
Genome Med; 2023 Nov; 15(1):103. PubMed ID: 38037155
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations.
Leiding JW; Okada S; Hagin D; Abinun M; Shcherbina A; Balashov DN; Kim VHD; Ovadia A; Guthery SL; Pulsipher M; Lilic D; Devlin LA; Christie S; Depner M; Fuchs S; van Royen-Kerkhof A; Lindemans C; Petrovic A; Sullivan KE; Bunin N; Kilic SS; Arpaci F; Calle-Martin O; Martinez-Martinez L; Aldave JC; Kobayashi M; Ohkawa T; Imai K; Iguchi A; Roifman CM; Gennery AR; Slatter M; Ochs HD; Morio T; Torgerson TR;
J Allergy Clin Immunol; 2018 Feb; 141(2):704-717.e5. PubMed ID: 28601685
[TBL] [Abstract][Full Text] [Related]
15. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
[TBL] [Abstract][Full Text] [Related]
16. DNA-Binding domain mutations confer severe outcome at an early age among STAT1 gain-of-function patients.
Scott O; Dadi H; Vong L; Pasternak Y; Garkaby J; Willett Pachul J; Mandola AB; Brager R; Hostoffer R; Nahum A; Roifman CM
Pediatr Allergy Immunol; 2022 Jan; 33(1):e13694. PubMed ID: 34738677
[TBL] [Abstract][Full Text] [Related]
17.
Pan M; Jiang C; Tse P; Achacoso N; Alexeeff S; Solorzano AV; Chung E; Hu W; Truong TG; Arora A; Sundaresan T; Suga JM; Thomas S; Habel LA
J Clin Oncol; 2022 Jan; 40(2):171-179. PubMed ID: 34843402
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Profiling of STAT1 Gain-of-Function Reveals Common and Mutation-Specific Fingerprints.
Giovannozzi S; Demeulemeester J; Schrijvers R; Gijsbers R
Front Immunol; 2021; 12():632997. PubMed ID: 33679782
[TBL] [Abstract][Full Text] [Related]
19. Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells.
Sconocchia T; Foßelteder J; Köhnke T; Majeti R; Reinisch A
J Vis Exp; 2023 Mar; (193):. PubMed ID: 36971438
[TBL] [Abstract][Full Text] [Related]
20. Clinical severity is correlated with age at seizure onset and biophysical properties of recurrent gain of function variants associated with SCN8A-related epilepsy.
Chung KM; Hack J; Andrews J; Galindo-Kelly M; Schreiber J; Watkins J; Hammer MF
Epilepsia; 2023 Dec; 64(12):3365-3376. PubMed ID: 37585367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]